Multidomain efficacy and safety of IL-17A and IL-17A/F inhibitors versus adalimumab in biologic-naïve psoriatic arthritis: A systematic review and Meta-analysis of comparative trials

Autoimmunity Reviews · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles